Evidence map›Paper›PMID 32201683›Full record

ArticleERJ open research2020

Is pulmonary arterial hypertension associated with interferon-β therapy for multiple sclerosis reversible? A case study to explore the complexity.

Anastasia Anthi, Eleni Stagaki, Loukianos Rallidis, Dimitrios Konstantonis, Maria-Eleftheria Evangelopoulos, Konstantinos Voumvourakis, Apostolos Armaganidis, Stylianos E Orfanos

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ERJ open research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 96% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Anastasia AnthiPulmonary Hypertension Clinic, "Attikon" Hospital, Athens, Greece.
Eleni StagakiPulmonary Hypertension Clinic, "Attikon" Hospital, Athens, Greece.
Loukianos RallidisPulmonary Hypertension Clinic, "Attikon" Hospital, Athens, Greece.
Dimitrios KonstantonisPulmonary Hypertension Clinic, "Attikon" Hospital, Athens, Greece.
Maria-Eleftheria EvangelopoulosDemyelinating Diseases Unit, Dept of Neurology, National and Kapodistrian University of Athens, Eginition Hospital, Athens, Greece.
Konstantinos Voumvourakis2nd Dept of Neurology, National and Kapodistrian University of Athens, "Attikon" Hospital, Athens, Greece.
Apostolos ArmaganidisPulmonary Hypertension Clinic, "Attikon" Hospital, Athens, Greece.ORCID https://orcid.org/0000-0002-6630-2648
Stylianos E OrfanosPulmonary Hypertension Clinic, "Attikon" Hospital, Athens, Greece.
National and Kapodistrian University of Athens · GRUniversity General Hospital Attikon · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID32201683
PMCPMC7073410
OpenAlexW3011541717

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.